Key facts
- It has raised $59.9M; the latest was Later Stage VC ($26.6M) in Sep 2025.
- Notable investors include Google for Startups, Qiming Venture Partners, iSeed Ventures, Llama Venture, Google Accelerator — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Fasikl
- ·The full record, as it builds
Funding rounds
No funding rounds for Fasikl are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fasikl
Developer of wearable neuro-AI therapeutic devices designed for alleviating tremor-related functional limitations. The company's device integrates artificial intelligence with bioelectronic medicine that continuously monitors and modulates neural activity through cloud-connected adaptive stimulation, enabling patients to adjust therapy in real time and use it independently or alongside medication.
- Sector
- Healthcare
- HQ
- Bloomington, MN, United States
- Founded
- 2019
- Employees
- 13
- Website
- fasikl.com/
- Ownership
- Privately Held (backing)
Fasikl doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fasikl shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fasikl in its N-PORT filings yet. We sweep new filings monthly.